SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.

This is a protocol.

Health topics: